FDA Roundup: September 9, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-9-2022

FDA Issues Safety Alert for Squamous Cell Carcinoma and Various Lymphomas in Scar Tissue around Breast Implants
http://www.fda.gov/news-events/press-announcements/fda-issues-safety-alert-squamous-cell-carcinoma-and-various-lymphomas-scar-tissue-around-breast

http://www.fda.gov/medical-devices/letters-health-care-providers/abbott-mitraclip-device-potential-clip-lock-malfunctions-letter-health-care-providers

Monkeypox Update: FDA Takes Significant Action to Help Expand Access to Testing
http://www.fda.gov/news-events/press-announcements/monkeypox-update-fda-takes-significant-action-help-expand-access-testing

Certain Philips Respironics Masks for BiPAP, CPAP Machines Recalled Due to Safety Issue with Magnets That May Affect Certain Medical Devices
http://www.fda.gov/news-events/press-announcements/certain-philips-respironics-masks-bipap-cpap-machines-recalled-due-safety-issue-magnets-may-affect

FDA Roundup: September 6, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-6-2022

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-respironics-alerts-customers-worldwide-updated-instructions-and-labeling-specific-sleep

FDA Roundup: September 2, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-september-2-2022

Moduladores y potenciadores para el tratamiento de personas con fibrosis quística con mutaciones Clase II (F508del) en el CFTR
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1391934

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-acid-sphingomyelinase-deficiency-rare-genetic-disease